Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
74.57
-0.88 (-1.17%)
May 17, 2024, 4:00 PM EDT - Market closed
Vaxcyte Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 96, with a low estimate of 80 and a high estimate of 113. The average target predicts an increase of 28.74% from the current stock price of 74.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 3 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +27.40% | May 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +27.40% | Apr 10, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $69 → $113 | Strong Buy | Maintains | $69 → $113 | +51.54% | Mar 12, 2024 |
| Needham | Needham | Strong Buy Maintains $73 → $95 | Strong Buy | Maintains | $73 → $95 | +27.40% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.40
from -4.14
EPS Next Year
-4.57
from -4.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 182.8M | 637.4M |
| Avg | n/a | n/a | n/a | 65.0M | 273.5M |
| Low | n/a | n/a | n/a | n/a | 14.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 880.6% |
| Avg | - | - | - | - | 320.8% |
| Low | - | - | - | - | -78.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.93 | -3.17 | -2.67 | -2.13 | -1.77 |
| Avg | -4.40 | -4.57 | -4.65 | -4.17 | -3.16 |
| Low | -4.66 | -5.48 | -5.56 | -5.40 | -5.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.